Company
Overview
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase 0 – IIa)
Phase 0-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Bioanalytical Services
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Bioanalytical Services
Scientific Library
Case Studies
Podcasts
Posters
Webinars
White Papers
Events
News
Contact Us
Study Participation
Medical Investigators
Careers at MDS
MDS Pharma Services News
September 30, 2009
MDS Pharma Services Earns ANVISA Certification to Support Entry to Fast-Growing Brazilian Pharmaceutical Market by Client Products
September 17, 2009
MDS Pharma Services to Host Global Scientific Symposia Series on Expediting Drug Discovery and Early Stage Development
Upcoming Events
December 2 2009 - December 4 2009
Barcelona, Spain
European Bioanalysis Forum
2004
MDS Pharma Services News Releases
MDS Pharma Services Responds to FDA Correspondence
December 24, 2004
- As part of its ongoing dialogue with the U.S. Food and Drug Administration (FDA) regarding certain bioequivalence studies conducted at its Montreal Bioanalytical facility between 2000 and 2003, MDS Pharma Services has received a written communication from the agency dated December 21, 2004.
MDS Pharma Services Announces New Senior Management Team and Structure
October 28, 2004
- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, is expanding its senior management team, effective November 1, 2004, when Gilbert Godin becomes president of MDS Pharma Services. "This new structure and its associated appointments balance the need for stability and continuity, through promotions from within, with the invigorating influence of new players," says Godin. "By moving from two business groups to three, the new structure offers the agility to better respond to emerging market forces, and focuses additional leadership resources on achieving our 2005 growth targets."
MDS Pharma Services Appoints New President
October 7, 2004
- MDS Inc. announced today that Gilbert Godin has been appointed as President, MDS Pharma Services effective November 1, 2004. Mr. Godin is currently Group Vice President, Early Stage Development at MDS Pharma Services and has been with MDS since 1999. MDS Pharma Services, provides contract research services to the global pharmaceutical and biotech industry for drug discovery and drug development.
Archives
2008
2007
2006
2005
2004
2003
2002
2001
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map